Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meike Scharenberg

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of Medicinal Chemistry|February 11, 2015
FimH antagonists: bioisosteres to improve the in vitro and in vivo PK/PD profileSimon Kleeb, Lijuan Pang, Katharina Mayer, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 12, 2024
Nonclinical and clinical characterization of MAU868, a novel human-derived monoclonal neutralizing antibody targeting BK polyomavirus VP1Johanna R Abend, Atul Sathe, Matthias B Wrobel, et al.
Science Translational Medicine|February 1, 2023
Anti-brolucizumab immune response as one prerequisite for rare retinal vasculitis/retinal vascular occlusion adverse eventsAnette C Karle, Matthias B Wrobel, Stephan Koepke, et al.
Nature Communications|October 7, 2016
Loss of immune tolerance to IL-2 in type 1 diabetesLouis Pérol, John M Lindner, Pamela Caudana, et al.
Scientific Reports|June 16, 2016
Exploring host-pathogen interactions through genome wide protein microarray analysisLuigi Scietti, Katia Sampieri, Irene Pinzuti, et al.
Molecular Cancer Therapeutics|August 28, 2020
Development of Anti-CD32b Antibodies with Enhanced Fc Function for the Treatment of B and Plasma Cell MalignanciesHaihui Lu, Ryan D Molony, Dongshu Chen, et al.
Blood|January 30, 2019
MAA868, a novel FXI antibody with a unique binding mode, shows durable effects on markers of anticoagulation in humansAlexander W Koch, Nikolaus Schiering, Samu Melkko, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Medicinal Chemistry|February 11, 2015
FimH antagonists: bioisosteres to improve the in vitro and in vivo PK/PD profileSimon Kleeb, Lijuan Pang, Katharina Mayer, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 12, 2024
Nonclinical and clinical characterization of MAU868, a novel human-derived monoclonal neutralizing antibody targeting BK polyomavirus VP1Johanna R Abend, Atul Sathe, Matthias B Wrobel, et al.
Science Translational Medicine|February 1, 2023
Anti-brolucizumab immune response as one prerequisite for rare retinal vasculitis/retinal vascular occlusion adverse eventsAnette C Karle, Matthias B Wrobel, Stephan Koepke, et al.
Nature Communications|October 7, 2016
Loss of immune tolerance to IL-2 in type 1 diabetesLouis Pérol, John M Lindner, Pamela Caudana, et al.
Scientific Reports|June 16, 2016
Exploring host-pathogen interactions through genome wide protein microarray analysisLuigi Scietti, Katia Sampieri, Irene Pinzuti, et al.
Molecular Cancer Therapeutics|August 28, 2020
Development of Anti-CD32b Antibodies with Enhanced Fc Function for the Treatment of B and Plasma Cell MalignanciesHaihui Lu, Ryan D Molony, Dongshu Chen, et al.
Blood|January 30, 2019
MAA868, a novel FXI antibody with a unique binding mode, shows durable effects on markers of anticoagulation in humansAlexander W Koch, Nikolaus Schiering, Samu Melkko, et al.
Pageof 2